Akston Biosciences
Beverly, US
Biotech
Founders & leadership
JM
James M. HerrimanExecutive Officer
RM
Robyn M. DavisDirector
LE
Lovick E. CannonDirector
TC
Todd C. ZionExecutive Officer, Director
TM
Thomas M. LancasterExecutive Officer, Director
Reported raises · per SEC filings
Form D private placements$5.2MraisedApr 2022 · 37 investors · Biotechnology
Rule 506(b)$7.9MraisedJun 2021 · 71 investors · Biotechnology
Rule 506(b)$1MraisedJun 2021 · 1 investors · Biotechnology
Rule 506(b)$5.1MraisedMay 2020 · 71 investors · Biotechnology
Rule 506(b)$2.5MraisedJun 2019 · 46 investors · Biotechnology
Rule 506(b)Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.